MedTrace Logo

Thoracic Specimen Registry

NCT04118660 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 7000

Last updated 2026-01-16

No results posted yet for this study

Summary

The purpose of the registry will be to support ongoing research in the etiology, early diagnosis, clinical management, and prognosis of lung cancer and other cancers and diseases of the thorax by developing a complete repository of specimens from patients with thoracic disease including but not limited to suspected lung cancer, mediastinal and pleural tumors, lung transplants and from patients at a very high risk of developing other thoracic cancers or other thoracic diseases.

Conditions

Interventions

OTHER

Tissue Banking

Blood, tissue, and fluid collection

Sponsors & Collaborators

Principal Investigators

  • Eric Edell, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2028-01-31
Completion
2028-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04118660 on ClinicalTrials.gov